{"id":"W4410804527","doi":"10.1200/jco.2025.43.16_suppl.e13135","title":"Phase 1 study of the anti–immunoglobulin-like transcript 3 (ILT3) monoclonal antibody (mAb) MK-0482 + pembrolizumab (pembro) + paclitaxel for previously untreated advanced triple negative breast cancer (TNBC).","year":2025,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Monoclonal antibody; Pembrolizumab; Triple-negative breast cancer; Antibody; Trastuzumab; Paclitaxel; Breast cancer; Cancer research; Virology; Cancer; Immunology; Immunotherapy; Immune system; Internal medicine","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001152794,0.001744164,0.001375659,0.000390936,0.0004122035,0.000746233,0.001033623,0.001287013,0.006733614],"category_scores_gemma":[0.0007068288,0.0008004362,0.0008984884,0.0003188003,0.0005712588,0.000671705,0.0003155801,0.002946332,0.001394442],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001137281,"about_ca_system_score_gemma":0.002181867,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001608696,"about_ca_topic_score_gemma":0.00491705,"domain_scores_codex":[0.9997206,0.0001281559,0.000008248001,0.00005456019,0.00003023223,0.00005813648],"domain_scores_gemma":[0.999625,0.00005439511,0.00009284513,0.00002705028,0.00003403466,0.0001665999],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.6689975,0.1673535,0.007201029,0.001400963,0.001414401,0.0003884788,0.0004079844,0.004025287,0.06422511,0.0004686414,0.009655337,0.07446188],"study_design_scores_gemma":[0.4781588,0.4995361,0.01092613,0.00004693727,0.0005480323,0.0002956105,0.00007161134,0.001129478,0.004023928,0.0002556745,0.004982871,0.00002490127],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9817913,0.001768039,0.0008918417,0.0005879179,0.0001738844,0.009015756,0.002398073,0.0001583392,0.003214874],"genre_scores_gemma":[0.9715316,0.002261958,0.003112668,0.001613719,0.0001992301,0.009653127,0.003935752,0.0000684516,0.007623519],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.006733614,"threshold_uncertainty_score":0.0225262,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1128501069790487,"score_gpt":0.5465878771365084,"score_spread":0.4337377701574596,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}